These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6766752)

  • 1. Ia antigen expression by human malignant lymphomas: correlation with conventional lymphoid markers.
    Halper JP; Knowles DM; Wang CY
    Blood; 1980 Mar; 55(3):373-82. PubMed ID: 6766752
    [No Abstract]   [Full Text] [Related]  

  • 2. Surface markers on leukemia and lymphoma cells: recent advances.
    Foon KA; Schroff RW; Gale RP
    Blood; 1982 Jul; 60(1):1-19. PubMed ID: 6805534
    [No Abstract]   [Full Text] [Related]  

  • 3. Surface phenotyping, histology and the nature of non-Hodgkin lymphoma in 157 patients.
    Habeshaw JA; Catley PF; Stansfeld AG; Brearley RL
    Br J Cancer; 1979 Jul; 40(1):11-34. PubMed ID: 314300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte surface markers in lymphoproliferative disorders.
    Aiuti F; Lacava V; Fiorilli M; Ciarla MV
    Acta Haematol; 1973; 50(5):275-83. PubMed ID: 4202631
    [No Abstract]   [Full Text] [Related]  

  • 5. Cell surface phenotype in lymphoproliferative disease.
    Aisenberg AC; Wilkes BM; Long JC; Harris NL
    Am J Med; 1980 Feb; 68(2):206-13. PubMed ID: 6965562
    [No Abstract]   [Full Text] [Related]  

  • 6. Malignant disease of the lymphoid system in immunological perspective.
    Hansen JA; Good RA
    Hum Pathol; 1974 Sep; 5(5):567-99. PubMed ID: 4137052
    [No Abstract]   [Full Text] [Related]  

  • 7. Current views on the diagnosis of lymphomas by surface and cytoplasmic markers.
    Lewis RE; Johnson WW; Cruse JM
    Surv Immunol Res; 1982; 1(2):162-72. PubMed ID: 6314466
    [No Abstract]   [Full Text] [Related]  

  • 8. Expression of Ia-like antigen in lymphatic leukaemias and non-hodgkin lymphomas in correlation with other surface markers.
    Bergmann L; Mitrou PS; Cherdron T; Holloway K; Jost J; Timm V; Zerth G
    Scand J Haematol; 1982 Sep; 29(3):224-34. PubMed ID: 6983113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunological aspects of malignant lymphoproliferative diseases].
    Rivero I; Diumenjo M
    Rev Clin Esp; 1977 Mar; 144(6):403-9. PubMed ID: 140441
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunological anomalies observed during hyperlymphocytic chronic lymphoid leukemia].
    Homberg JC; Cartron J; Ropars C; Cavaroc M; Salmon C
    Nouv Rev Fr Hematol; 1971; 11(3):476-83. PubMed ID: 4108309
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunologic definition of lymphocytes: functions and markers.
    Stathopoulos G; Davies AJ
    Recent Results Cancer Res; 1976; (56):17-23. PubMed ID: 1087443
    [No Abstract]   [Full Text] [Related]  

  • 12. [T-and B-lymphocytes in lymphoproliferative syndromes].
    Girard JP; Fernandes B
    Schweiz Med Wochenschr; 1975 Sep; 105(37):1174-9. PubMed ID: 814616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody studies in B(non-T)-cell malignancies.
    Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
    Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface immunoglobulin in immunoproliferative diseases.
    Teodorescu M; Mayer EP
    Ann Clin Lab Sci; 1978; 8(5):353-65. PubMed ID: 101125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Surface markers of human lymphocyte subpopulations, their biological significance and a study of states of immunological deficits and lymphoproliferative disorders].
    Gupta S; Good RA
    Pol Arch Med Wewn; 1977 Feb; 57(2):149-72. PubMed ID: 403513
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunology of non-Hodgkin lymphomas].
    Ricci C; Cascio G; Bellone G; Borio T; Novarini M; Riposio A; Bozzone D
    Minerva Med; 1983 May; 74(20):1145-56. PubMed ID: 6431332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cellular content of non Hodgkin lymphomas: a comprehensive analysis using monoclonal antibodies and other surface marker techniques.
    Habeshaw JA; Bailey D; Stansfeld AG; Greaves MF
    Br J Cancer; 1983 Mar; 47(3):327-51. PubMed ID: 6338896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The spectrum of B cell neoplasia.
    Deegan MJ
    Henry Ford Hosp Med J; 1984; 32(1):20-30. PubMed ID: 6204956
    [No Abstract]   [Full Text] [Related]  

  • 19. [Blastic lymphocyte transformation caused by phytohemagglutinin in patients with lymphoproliferative diseases].
    Mantovani G; Petrini MT; Tognella S; Grifoni V
    Boll Soc Ital Biol Sper; 1972 Jul; 48(14):381-5. PubMed ID: 4628299
    [No Abstract]   [Full Text] [Related]  

  • 20. Clonal evolution of T-cell prolymphocytic leukemia to a T-large-cell lymphoma. A morphologic and immunologic study.
    Forman SJ; Nathwani BN; Woda BA; Paladugu RR; Farbstein MJ
    Arch Pathol Lab Med; 1985 Dec; 109(12):1081-4. PubMed ID: 3878141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.